MPV

Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read More

New Vanderbilt-led research published in the Journal of Infectious Diseases has identified an antibody that shows promise in preventing and treating human metapneumovirus (MPV) and respiratory syncytial virus (RSV) — the two leading causes of respiratory infections in young children. Read More